[Federal Register Volume 67, Number 80 (Thursday, April 25, 2002)]
[Notices]
[Pages 20542-20544]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-10261]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Privacy Act of 1974: Establishment of New Privacy Act System of 
Records

AGENCY: Substance Abuse and Mental Health Services Administration 
(SAMHSA), DHHS.

ACTION: Privacy Act of 1974: Notice of new system of records

-----------------------------------------------------------------------

SUMMARY: The Substance abuse and mental Health Services Administration 
(SAMHSA) is establishing a new system of records in order to implement 
the provisions of the Controlled Substances Act as amended (21 U.S.C. 
823(g)(2)).

SUPPLEMENTARY INFORMATION: New legislation permits practitioners to 
seek waivers from the separate registration requirements required under 
the Controlled Substances Act for practitioners who use narcotic 
treatment medications in the maintenance or detoxification treatment of 
opiate addition. The Secretary of the Department of Health and Human 
Services has delegated to SAMHSA the responsibility of determining 
whether practitioners meet the requirements for these waivers. To be 
eligible for waivers, practitioners must be licensed physicians, must 
be registered by Drug Enforcement Administration (DEA), must fulfill 
qualifications for training and experience, and must make written 
certifications about treatment capacity and patent load. Practitioners 
determined eligible for a waiver, will receive a unique identification 
number from DEA, and will be eligible to prescribe certain approved 
opioid treatment medications.
    This new system of records will permit SAMHSA to conduct its 
responsibilities to determine whether practitioners meet requirements 
for waivers. SMHSA will use the information from this system to verify 
DEA registration status, to verify medical license status, and to 
verify training and experience qualifications. In addition, for those 
practitioners who consent, SMHSA will use limited information from this 
system to augment the Substance Abuse Treatment Facility Locator. The 
Treatment Facility Locator is a web-based system that permits 
individuals seeking treatment to locate treatment providers.

DATES: SAMHSA invites interested persons to submit comments on the 
proposed new system on or before May 28, 2002. SAMHSA will adopt this 
new

[[Page 20543]]

system without further notices on June 10, 2002 unless comments are 
received that would result in a contrary determination.

ADDRESSES: Please address comments to the SAMHSA Privacy Act Officer, 
Division of Administrative Services, Room 6-101, Parklawn building, 
Substance Abuse and Mental Health Services Administration, 5600 Fishers 
Lane, Rockville, Maryland 20857. We will make comments available for 
public inspection at the above address during normal business hours, 
8:30 a.m.-5 p.m.

FOR FURTHER INFORMATION CONTACT: Nichols Reuter, Supervisory, Public 
Health Advisor, Office of Pharmacologic and Alternative Therapies, 
Center for Substance Abuse Treatment/SAMHSA, 5600 Fishers Lane, 
Rockwall II, suite 740, Rockville, Maryland 20857 (301) 443-0547.

    Dated: April 4, 2002.
Richard Kopanda,
Executive Officer, Substance Abuse and Mental Health Services 
Administration.
09-30-0052

System Name:
    Opioid Treatment Waiver Notification System.

Security Classification:
    None.

System Location:
    Office of Pharmacologic and Alternative Therapies, Center for 
Substance Abuse Treatment, Substance Abuse and Mental Health Services 
Administration, Room 7-40, Rockwall II Building, 5600 Fishers Lane, 
Rockville, Maryland 20857.

Categories of Individuals Covered by the System:
    An individual practitioner (physician) or a practitioner in a group 
practice who submits a written notification of intent to use schedule 
III, IV, V opioid drugs for the maintenance or detoxification treatment 
of opiate addiction under 21 U.S.C. 823(g)(2).

Categories of Records in the System:
    Physician name, address, phone, facsimile, state medical license 
number, DEA registration number, credentialing and specialized training 
information. In addition, for those practitioners in group practices, 
the group practice EIN.

Authority for Maintenance of the System:
    Controlled Substance Act (21 U.S.C. 823(g)(2)).

Purposes(s):
    To determine (as required by 21 U.S.C. 823(g)(2)) whether 
practitioners who submit notifications meet all of the requirements for 
a waiver under 21 U.S.C. 823(g)(2)(B). The established criteria for a 
waiver include: a written notification that states the practitioner's 
name, the practitioner's registration under 21 U.S.C. 823(f), the 
practitioner's physician license under State law, and the qualifying 
physician criteria. The record system will also allow disclosure with 
consent of limited information to the Treatment Facility Locator.

Routine Uses of Records Maintained in the System, Including Categories 
of Users and the Purposes of Such Uses:
    A. Medical speciality societies to verify practitioner 
qualifications.
    B. Other federal law enforcement and regulatory agencies for law 
enforcement and regulatory purposes.
    C. State and local law enforcement and regulatory agencies for law 
enforcement and regulatory purposes.
    D. Persons registered under the Controlled Substance Act (Pub. L. 
91-513) for the purpose of verifying the registration of customers and 
practitioners.
    E. Disclosure may be made to a congressional office from the record 
of an individual in response to a verified inquiry from the 
congressional office made at the written request of that individual.
    F. The Department of Health and Human Services (HHS) may disclose 
information from this system of records to the Department of Justice, 
or to a court or other tribunal, when (a) HHS, or any component 
thereof; or (b) any HHS employee in his or her official capacity; or 
(c) any HHS employee in his or her individual capacity where the 
Department of Justice (or HHS, where it is authorized to do so) has 
agreed to represent the employee; or (d) the United States or any 
agency thereof where HHS determines that the litigation is likely to 
affect HHS or any of its components, is a party to litigation or has an 
interest in such litigation, and HHS determines that the use of such 
records by the Department of Justice, the court or other tribunal is 
relevant and necessary to the litigation and would help in the 
effective representation of the governmental party, provided however, 
that in each case, HHS determines that such disclosure is compatible 
with the purpose for which the records were collected.
    G. SAMHSA intends to disclose information from this system to an 
expert, consultant, or contractor (including employees of the 
contractor) of SAMHSA if necessary to further the implementation and 
operation of this program.
    Disclosure limited to individual's name, address, and phone number 
will also be made to the SAMHSA Treatment Facility Locator pursuant to 
express consent.

Disclosures to Consumer Reporting Agencies:
    None.

Policies and Practices for Storing, Retrieving, Accessing, Retaining, 
and Disposing of Records in the System Storage:
    Documents are filed in manual files in enclosed and/or locked file 
cabinets and in secured computers. The same basic data is maintained in 
an automated system for quick retrieval.

Retrievability:
    Records are retrieved by the individual practitioner's name and 
cross indexed by the practitioner's DEA registration number.

Safeguards:
    1. Authorized Users: Federal contract and support personnel.
    2. Physical Safeguards: All folders are in file cabinets in a room 
that is locked after business hours in a building with controlled entry 
(picture identification). Files are withdrawn from cabinet for Federal 
staff who have a need to know by a sign in and out procedure.
    3. Procedural Safeguards: Access to records is strictly limited to 
those staff members trained in accordance with the Privacy Act.
    4. Implementation Guidelines: DHHS Chapter 45-13 of the General 
Administration Manual.

Retention and Disposal:
    Records are retained for a period of five years and then destroyed.

System Manager(s) and Address:
    Nicholas Reuter, Office of Pharmacologic and Alternative Therapies, 
Center for Substance Abuse Treatment, Substance Abuse and Mental Health 
Services Administration, Room 6-70, Rockwall II Building, 5600 Fishers 
Lane, Rockville, Maryland 20857.

Notification Procedures:
    To determine if a record exists, write to the appropriate System 
Manager at the Address above or appear in person to the Division of 
Contracts Management. An individual may learn if a record exists about 
himself/herself upon written request with notarized signature. An 
individual who is the subject of records maintained in this record 
system may also request an accounting of all disclosures that have been 
made for that individual's records, if any.

[[Page 20544]]

Record Access Procedures:
    Same as notification procedures. Requesters should specify the 
record contents being sought. An individual may also request an 
accounting of disclosures of his/her records, if any.

Contesting Record Procedures:
    Contact the official at the address specified under notification 
procedures above and identify the record, specify the information being 
contested, the corrective action sought, along with supporting 
information to show how the record is inaccurate, incomplete, untimely, 
or irrelevant.

Record Source Categories:
    Individual practitioner notifications of intent to use Schedule 
III, IV, or V opioid drugs for the Maintenance and Detoxification 
Treatment of Opiate Addiction under 21 USC Sec. 823(g)(2).

System Exempted From Certain Provisions of the Act:
    None.

[FR Doc. 02-10261 Filed 4-24-02; 8:45 am]
BILLING CODE 4162-20-M